Premium
Two homegrown private equity firms have teamed up with an Asian alternative investment firm to strike a deal for Chennai-based Anjan Drug Pvt. Ltd, three people close to the development said. CX Partners, Samara Capital and a Hong Kong-based investment firm have come together to float a Singapore-based entity to acquire ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
